HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Altfeld Selected Research

M Altfeld Research Topics

Disease

12Infections
10/2016 - 09/2000
3HIV Infections (HIV Infection)
01/2016 - 04/2000
2Persistent Infection
09/2001 - 01/2001
2Virus Diseases (Viral Diseases)
12/2000 - 09/2000
2Acquired Immunodeficiency Syndrome (AIDS)
09/2000 - 05/2000
1Viremia
07/2006
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
07/2006
1Disease Progression
07/2001

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
10/2016 - 02/2001
5EpitopesIBA
09/2002 - 01/2001
3AIDS VaccinesIBA
09/2002 - 02/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2016 - 04/2000
2Messenger RNA (mRNA)IBA
10/2016 - 04/2000
2RNA (Ribonucleic Acid)IBA
07/2006 - 09/2000
2Peptides (Polypeptides)IBA
02/2003 - 12/2000
1romidepsin (FK228)FDA Link
10/2016
1gag Gene Products (gag Protein)IBA
10/2016
1Tenofovir (Viread)FDA Link
01/2016
1HLA-B57 antigenIBA
03/2004
1difluprednateFDA Link
02/2003
1EnzymesIBA
02/2003
1Interferon-gamma (Interferon, gamma)IBA
02/2003
1Protein Subunits (Protein Subunit)IBA
02/2003
1HLA Antigens (Human Leukocyte Antigens)IBA
07/2001
1Antiviral Agents (Antivirals)IBA
01/2001
1KynurenineIBA
09/2000
1Quinolinic AcidIBA
09/2000
1Tryptophan (L-Tryptophan)FDA Link
09/2000
1Interleukin-10 (Interleukin 10)IBA
04/2000
1CytokinesIBA
04/2000
1Interleukin-4 (Interleukin 4)IBA
04/2000

Therapy/Procedure

2Therapeutics
01/2001 - 09/2000
1Highly Active Antiretroviral Therapy (HAART)
07/2006
1Aftercare (After-Treatment)
07/2006
1Secondary Prevention
01/2001
1Immunotherapy
09/2000
1Critical Care (Surgical Intensive Care)
05/2000